Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
In 1994, Reckitt Benckiser Group plc (RB) established the Buprenorphine Business Group, to which Indivior can trace its history of over 20 years.
In US, Drug Abuse Treatment Act of 2000 legislation permitted qualified physicians to prescribe and dispense specifically approved Schedule III, IV and V narcotic medications for the treatment of opioid dependence in settings other than an opioid treatment program
DATA 2000 (US) cap was extended from 30 to 100 patients for physicians with at least one year's clinical experience with buprenorphine
February 2014, the Indivior entered into an agreement with AntiOp, Inc. to co-develop a naloxone nasal spray to aid in the reversal of opioid overdose with the option to acquire all rights to the product upon receipt of regulatory and marketing approval
Following the September 2014 demerger from RB, Indivior PLC was listed as an independent company on the London Stock Exchange.
In 2019, Indivior expanded its treatment portfolio to offer a medication for the treatment of schizophrenia for adults in the United States and announced a licensing agreement with a well-established and experienced partner to bring this treatment to patients in Canada.
© 2020 Indivior PLC | INDIVIOR is a registered trademark of Indivior UK Limited.
Rate how well Indivior lives up to its initial vision.
Do you work at Indivior?
Does Indivior communicate its history to new hires?
Zippia gives an in-depth look into the details of Indivior, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Indivior. The employee data is based on information from people who have self-reported their past or current employments at Indivior. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Indivior. The data presented on this page does not represent the view of Indivior and its employees or that of Zippia.
Indivior may also be known as or be related to Indivior, Indivior Inc and Indivior Plc.